Nirajan Regmi

Nirajan Regmi practices at Willis Knighton Bossier in Shreveport, Louisiana.

Nirajan Regmi's NPI, 1164913950, was assigned on May 29, 2018. Nirajan Regmi graduated from Tribhuvan University Inst of Medicine in 2015. Nirajan Regmi holds New York license 312886.

Nirajan Regmi's primary practice is Willis Knighton Bossier, at 2600 Greenwood Rd, Shreveport, LA 71103 in Caddo Parish. The practice phone is (318) 212-7003.

Nirajan Regmi's primary practice is Willis Knighton Bossier in Shreveport, Louisiana.

Dmand AI tracks the electronic health record (EHR) system at each site where Nirajan Regmi practices. Vendor and product names are available with a free account.

Internal medicine is Nirajan Regmi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nirajan Regmi is licensed in New York.

Dmand AI lists acute diabetes, anemia, arthritis, atrial fibrillation and flutter, cardiac arrhythmia, chronic hypertension, congestive heart failure and electrolyte disorders among the conditions Nirajan Regmi treats.

CMS data shows 1,155 Medicare services from Nirajan Regmi across 4 procedure codes in 2024, for 373 Medicare patients. Medicare paid $102,067 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 373 Medicare patients who saw Nirajan Regmi in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nirajan Regmi's median patient age at 75, with 30% women.

In 2024, Nirajan Regmi wrote 605 Medicare Part D claims for 263 patients. 87% of them were for generic drugs. CMS names the drug for 326 of them, across 18 drugs with 11 or more claims each, at $14,341 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

Dmand AI links 1 paper to Nirajan Regmi in 2020. Nirajan Regmi's most frequent co-authors are Sreedhar Reddy Adapa, MD, Mamtha Balla, MD, MPH and Mohamed Ali Mohamed Merghani.

CMS Open Payments shows 11 general payments to Nirajan Regmi from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 91% of the total. Stryker Corporation paid the most, $149.

Nirajan Regmi graduated from Tribhuvan University Inst of Medicine in 2015.

Nirajan Regmi is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.